Patents by Inventor Juan J. Miret

Juan J. Miret has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for Inhibiting Cell Proliferation in EGFR-Driven Cancers
    Publication number: 20140024620
    Abstract: The invention features a method for treating patients who have an EGFR-driven cancer, which is, or has become, refractory to a tyrosine kinase inhibitor, such as eriotinib and gefitinib, by administering a compound of formula (I) to the patient. The invention also features treating EGFR-driven cancers having an EGFR mutation identified herein.
    Type: Application
    Filed: October 14, 2011
    Publication date: January 23, 2014
    Applicant: ARIAD PHARMACEUTICALS, INC.
    Inventors: David C. Dalgarno, William C. Shakespeare, Xiaotian Zhu, Victor M. Rivera, Juan J. Miret
  • Genetic assays for trinucleotide repeat mutations in eukaryotic cells
    Patent number: 6489115
    Abstract: A method for assaying trinucleotide repeat mutations in eukaryotic cells is provided.
    Type: Grant
    Filed: December 21, 2000
    Date of Patent: December 3, 2002
    Assignee: The Board of Regents of the University of Nebraska
    Inventors: Robert S. Lahue, Juan J. Miret, Richard Pelletier
  • Genetic assays for trinucleotide repeat mutations in eukaryotic cells
    Publication number: 20020119439
    Abstract: A method for assaying trinucleotide repeat mutations in eukaryotic cells is provided.
    Type: Application
    Filed: December 21, 2000
    Publication date: August 29, 2002
    Inventors: Robert S. Lahue, Juan J. Miret, Richard Pelletier